Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aquestive Therapeutics, Inc. | SVP Sales and Marketing | Common Stock | 160K | $423K | $2.65 | Mar 7, 2025 | Direct |
Aquestive Therapeutics, Inc. | SVP Sales and Marketing | Non-Qualified Stock Option (right to buy) | 35K | Mar 7, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AQST | Aquestive Therapeutics, Inc. | Mar 7, 2025 | 3 | -$14.4K | 4 | Mar 11, 2025 | SVP Sales and Marketing |
AQST | Aquestive Therapeutics, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | SVP Sales and Marketing |
AQST | Aquestive Therapeutics, Inc. | Jun 3, 2024 | 0 | $0 | 3/A | Jun 12, 2024 | SVP Sales and Marketing |
AQST | Aquestive Therapeutics, Inc. | Jun 3, 2024 | 0 | $0 | 3 | Jun 11, 2024 | SVP Sales and Marketing |